Literature DB >> 12031891

Apolipoprotein E isoform mediated regulation of nitric oxide release.

Candice M Brown1, Elizabeth Wright, Carol A Colton, Patrick M Sullivan, Daniel T Laskowitz, Michael P Vitek.   

Abstract

Progressive dysfunction and death of neurons in Alzheimer's dementia is enhanced in patients carrying one or more APOE4 alleles who also display increased presence of oxidative stress markers. Modulation of oxidative stress is a nontraditional and physiologically relevant immunomodulatory function of apolipoprotein E (apoE). Stimulated peritoneal macrophages from APOE-transgenic replacement (APOE-TR) mice expressing only human apoE3 or human apoE4 protein isoforms were utilized as mouse models to investigate the role of apoE protein isoforms and gender in the regulation of oxidative stress. Macrophages from male APOE4/4-TR mice produced significantly higher levels of nitric oxide than from male APOE3/3-TR mice, while macrophages from female APOE3/3-TR and female APOE4/4-TR mice produced the similar levels of nitric oxide. Primary cultures of microglial cells of APOE4 transgenic mice also produced significantly more nitric oxide than microglia from APOE3 transgenic mice. These data suggest a potentially novel mechanism for gender-dependent and apoE isoform-dependent immune responses that parallel the genetic susceptibility of APOE4 carriers for the development of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031891     DOI: 10.1016/s0891-5849(02)00803-1

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  31 in total

1.  ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain.

Authors:  Veera Venkata Ratnam Bandaru; Juan Troncoso; David Wheeler; Olga Pletnikova; Jessica Wang; Kathy Conant; Norman J Haughey
Journal:  Neurobiol Aging       Date:  2007-09-20       Impact factor: 4.673

Review 2.  The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.

Authors:  Hong-liang Zhang; Jiang Wu; Jie Zhu
Journal:  J Biomed Biotechnol       Date:  2010-02-16

Review 3.  Antioxidant gene therapy against neuronal cell death.

Authors:  Juliana Navarro-Yepes; Laura Zavala-Flores; Annadurai Anandhan; Fang Wang; Maciej Skotak; Namas Chandra; Ming Li; Aglaia Pappa; Daniel Martinez-Fong; Luz Maria Del Razo; Betzabet Quintanilla-Vega; Rodrigo Franco
Journal:  Pharmacol Ther       Date:  2013-12-12       Impact factor: 12.310

Review 4.  Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.

Authors:  D Allan Butterfield; Mark P Mattson
Journal:  Neurobiol Dis       Date:  2020-02-06       Impact factor: 5.996

Review 5.  Searching for genes that matter in acute kidney injury: a systematic review.

Authors:  Jonathan C T Lu; Steven G Coca; Uptal D Patel; Lloyd Cantley; Chirag R Parikh
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 8.237

6.  Polymorphism in apolipoprotein E among migraineurs and tension-type headache subjects.

Authors:  Ravi Gupta; Vivek Kumar; Kalpana Luthra; Basudeb Banerjee; Manjeet Singh Bhatia
Journal:  J Headache Pain       Date:  2009-01-31       Impact factor: 7.277

Review 7.  Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice.

Authors:  Donna M Wilcock; Carol A Colton
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-03       Impact factor: 4.388

Review 8.  Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors.

Authors:  Mariana F Uchoa; V Alexandra Moser; Christian J Pike
Journal:  Front Neuroendocrinol       Date:  2016-09-17       Impact factor: 8.606

9.  Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1.

Authors:  Partha S Bhattacharjee; Donna M Neumann; Timothy P Foster; Saadallah Bouhanik; Christian Clement; Dass Vinay; Hilary W Thompson; James M Hill
Journal:  Exp Eye Res       Date:  2008-05-18       Impact factor: 3.467

Review 10.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.